PAPER Hirabayashi S, Uyeda A, Manabe I, Yonezu Y, Saito T, Saido TC, Misawa H, Ogasawara Y, Kinoshita K, Muramatsu R
SEARCH RESULTS
1781 RESULTS
PAPER Piro-Gambetti B, Krinsky-McHale S, Kovacs C, Handen B, Christian B, Laymon CM, Minhas D, Luo W, Yoon DM, Fleming VL, Schworer E, Kirkorian H, Hartley SL, Alzheimer Biomarkers Consortium‐Down Syndrome
Eye Tracking as a Tool for Detecting Alzheimer's Disease in People With Down Syndrome.
J Intellect Disabil Res. 2025 Feb 10; Epub 2025 Feb 10 PubMed.PAPER Haag L, Lancini E, Yakupov R, Ziegler G, Yi YJ, Lüsebrink F, Glanz W, Peters O, Spruth EJ, Altenstein S, Priller J, Schneider LS, Wang X, Preis L, Brosseron F, Roy-Kluth N, Fliessbach K, Wagner M, Wolfsgruber S, Kleineidam L, Ramirez A, Spottke A, Jessen F, Wiltfang J, Schneider A, Hansen N, Rostamzadeh A, Buerger K, Ewers M, Perneczky R, Janowitz D, Rauchmann BS, Teipel S, Kilimann I, Goerss D, Laske C, Munk MH, Heneka M, Dechent P, Hetzer S, Scheffler K, Düzel E, Betts MJ, Hämmerer D
CSF biomarkers are differentially linked to brain areas high and low in noradrenaline, dopamine and serotonin across the Alzheimer's disease spectrum.
Brain Commun. 2025;7(1):fcaf031. Epub 2025 Jan 23 PubMed.PAPER Almehdi AM, Aboubaker DH, Hamdy R, El-Keblawy A
Nanotherapeutic smart approaches for combating Alzheimer's disease and overcoming existing obstacles: A novel eco-friendly green approach.
Toxicol Rep. 2025 Jun;14:101906. Epub 2025 Jan 27 PubMed.PAPER Li G, Chen B, Sun W, Liu Z
A stacking classifier for distinguishing stages of Alzheimer's disease from a subnetwork perspective.
Cogn Neurodyn. 2025 Dec;19(1):38. Epub 2025 Feb 5 PubMed.PAPER Murata N, Nishii S, Usuha R, Kodaka A, Fujimori M, Sugawara H, Kiriyama T, Uchikado H, Okumura Y, Takebe T
A Gamified N-back App for Identifying Mild-cognitive Impairment in Older Adults.
JMA J. 2025 Jan 15;8(1):174-182. Epub 2024 Dec 20 PubMed.PAPER Shen C, Wang H, Djiotsop AN, Wiener RC, Pathak M, Mitra S, Findley PA, Sambamoorthi U
Association of reported sleep disturbances with objectively assessed mild cognitive impairment among adults in the United States.
SAGE Open Med. 2025;13:20503121251317912. Epub 2025 Feb 6 PubMed.PAPER Wen C, Gan JH, Liu S, Lu H, Wang LC, Wu H, Shi ZH, Ji Y
Enlarged perivascular spaces correlate with blood-brain barrier leakage and cognitive impairment in Alzheimer's disease.
J Alzheimers Dis. 2025 Feb 9;:13872877251317220. Epub 2025 Feb 9 PubMed.PAPER Jang JW, Lee SH, Kim T, Lee E, Park SW, Yeo NY, Kim YJ
Hearing loss and the risk of dementia: A longitudinal analysis of the Korean National Health Insurance Service Senior Cohort.
J Alzheimers Dis. 2025 Feb 9;:13872877251316805. Epub 2025 Feb 9 PubMed.PAPER Amro I, Hamadi AM, Salem AA, Chivese T, Wilkins SS, Khaled SM
Population-Based Norms for the Montreal Cognitive Assessment in Arab Adults.
Brain Behav. 2025 Feb;15(2):e70287. PubMed.PAPER Irmady K, Przedborski S
Progression in Parkinson's Disease.
Cold Spring Harb Perspect Med. 2025 Feb 10; Epub 2025 Feb 10 PubMed.PAPER Zhou ZH, Xing HY, Liang Y, Gao J, Liu Y, Zhang T, Zhu L, Qian JL, Zhou C, Li G
[Molecular mechanism of verbascoside in promoting acetylcholine release of neurotransmitter].
Zhongguo Zhong Yao Za Zhi. 2025 Jan;50(2):335-348. PubMed.PAPER Li Y, Zhang LL, Zhao C, Zhao HM, Wang Y, Fu JL, Zhang J, Zhang N, Xu HD
[Effect of Eucommiae Cortex extract mediated by ERβ/JNK pathway on learning and memory ability of APP/PS1 double-transgenic mice].
Zhongguo Zhong Yao Za Zhi. 2025 Jan;50(2):285-293. PubMed.PAPER Jia X, Zhao X, Tan W, Wang Z, Du J, Guo Z, Wang T, Xu M, Liu C
Characterization of pecan, hickory, and walnut phospholipids and the comparable effects of pecan phospholipids with soy phospholipids on scopolamine-induced dementia in mice.
J Food Sci. 2025 Feb;90(2):e70055. PubMed.PAPER Nahid S, Saeedi S, Hopkins CR
Phosphodiesterase 4 (PDE4) and neurological disorders: A promising frontier in neuropharmacology.
Adv Pharmacol. 2025;102:159-209. Epub 2024 Oct 22 PubMed.Current Filters
- Date Range : Past 30 Days x